Sepsis is the body's systemic inflammatory response to infection and can progress to severe sepsis, septic shock and ultimately multiple organ failure.
Early diagnosis and appropriate treatment of severe sepsis is vital to improve the patient's chance of survival.
Heparin Binding Protein is a new marker which has been shown to be useful in identifying patients on admission to the Emergency Department who are at risk of developing severe sepsis with circulatory failure.
Click the image to download our brochure
Published data suggests that Heparin Binding Protein exhibits superior performance over existing biomarkers for the assessment of severe sepsis.
Axis-Shield launched the first CE-marked assay for measuring Heparin Binding Protein in 2012.
For more information on this important new marker please visit www.heparinbindingprotein.com
A pioneering organisation focused on the development and manufacturing of important and innovative in vitro diagnostic tests for use in clinical laboratories and at the point of care.
As a general marker of overall health status, few tests carry greater predictive weight than Homocysteine. The amount of Homocysteine in your blood is one of the best independent indicators of how healthy you are.